What if prostate cancer is no longer the greatest threat to a man after treatment? Dr. Shalini Moningi joins Dr. Manuj Agarwal to examine cardiovascular outcomes after high-risk prostate cancer treatment. Using long-term brachytherapy data as the starting point, they discuss ADT duration, erectile dysfunction as a vascular clue, smoking, exercise, multidisciplinary risk reduction, and why cancer control should be paired with cardiovascular prevention.


Featuring:

  • Shalini Moningi, MD


Host:

  • Manuj Agarwal, MD,


Rss Apple Podcaster
Podden och tillhörande omslagsbild på den här sidan tillhör American Brachytherapy Society. Innehållet i podden är skapat av American Brachytherapy Society och inte av, eller tillsammans med, Poddtoppen.